<DOC>
	<DOCNO>NCT01761201</DOCNO>
	<brief_summary>A multicenter , prospective , non-inferiority , randomized open clinical trial compare levofloxacin isoniazid treatment latent tuberculosis infection patient eligible liver transplantation . Patients 18 year age wait list liver transplantation . Sample size : n=870 patient . HYPOTHESIS Levofloxacin treatment latent tuberculosis infection , begin wait list liver transplantation , safe less effective isoniazid treatment begin transplantation liver function stable .</brief_summary>
	<brief_title>`` Efficacy Safety Levofloxacin v Isoniazid Latent Tuberculosis Infection Liver Transplant Patients '' .</brief_title>
	<detailed_description>Primary Objective 1 . To demonstrate incidence tuberculosis patient latent tuberculosis infection treat levofloxacin high observed patient treat isoniazid . Secondary Objective 2 . To demonstrate efficacy levofloxacin limited adverse effect , pay particular attention hepatotoxicity .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Liver transplantation candidate age â‰¥ 18 year , clinical radiological evidence active tuberculosis negative pregnancy test ( applicable ) must meet one follow criterion : PPD skin test ( initial `` booster effect '' ) &gt; 5 mm . Alternatively , determination may make interferon gamma ( IFNg ) production PPDstimulated lymphocytes use QuantiferonTB ELISPOT assay . Past history tuberculosis properly treat . Past history contact patient active TB . Chest xray consistent past untreated TB ( apical fibronodular lesion , calcify solitary nodule , calcify lymph node pleural thicken ) . The patient must give write informed consent . Lack consent participate study . Intolerance allergy levofloxacin isoniazid . Documented contact tuberculosis resistant levofloxacin isoniazid . Treatment previous month drug potential activity Mycobacterium tuberculosis , ( especially quinolones ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Prophylaxis</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Transplant recipient</keyword>
	<keyword>Transplant wait list</keyword>
</DOC>